Fig. 3
From: Myocyte enhancer factor 2D provides a cross-talk between chronic inflammation and lung cancer
mRNA expression of MEF2s in different LPS-activated lung cell lines. a qRT-PCR analysis of MEF2s expression in total mRNA harvested from A549 cells challenged with PBS (LPS 0 μg/ml) or LPS at 0.01, 0.1, 1 μg/ml for 4 h; b qRT-PCR analysis of MEF2s expression in total mRNA harvested from HBE cells challenged with PBS (LPS 0 μg/ml) or LPS at 0.01, 0.1, 1 μg/ml for 4 h; c qRT-PCR analysis of MEF2s expression in total mRNA harvested from BEAS-2B cells challenged with PBS (LPS 0 μg/ml) or LPS at 0.01, 0.1, 1 μg/ml for 4 h. Data were presented as mean ± S.E.M and each group had at least six measurements (*p < 0.05, **p < 0.01, ***p < 0.001, as compared with control group)